What is the Share Price of Jenburkt Pharmaceuticals Ltd?
- Answer Field
-
The share price of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1038.40.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, JENBURKT PHARMACEUTICALS LTD. share price is currently at ₹ 1040, which is up by ₹ 7.25 from its previous closing. Today, the stock has fluctuated between ₹ 967.85 and ₹ 1043.00. Over the past year, JENBURKT PHARMACEUTICALS LTD. has achieved a return of 39.74 %. In the last month alone, the return has been 1.75 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 36.89 |
Operating Expense | 28.96 |
Net Profit | 6.51 |
Net Profit Margin (%) | 17.64 |
Earnings Per Share (EPS) | 14.75 |
EBITDA | 10.39 |
Effective Tax Rate (%) | 31.65 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2959.45 | 58.70 | 29.97 | 50134.87 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc.
Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.
The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.
In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.
The share price of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1038.40.
The market cap of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 4,58.30 Cr. as of now.
The 52 Week High and Low of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1375.00 and ₹ 730.00.
You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 39.74%.
Jenburkt Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1038.40 as on Apr 30 2025 03:29 PM.
The market cap of Jenburkt Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 4,58.30 as on Apr 30 2025 03:29 PM.
As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Jenburkt Pharmaceuticals Ltd share is 14.59.
As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Jenburkt Pharmaceuticals Ltd share is 357.46.
You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Jenburkt Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Jenburkt Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found